Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Thomas Farge, Jean Nakhle, Damien Lagarde, et al.
Cancer Research (2023) Vol. 83, Iss. 17, pp. 2824-2838
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Hao-Ran Jin, Jin Wang, Zijing Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 140
Lipid droplets provide metabolic flexibility for cancer progression
Rémi Safi, Pablo Menéndez, Albert Pol
FEBS Letters (2024) Vol. 598, Iss. 10, pp. 1301-1327
Open Access | Times Cited: 17
Ang-1 and VEGF: central regulators of angiogenesis
Yuanqin Zhao, Bo Yu, Yanxia Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 12
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 7
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Fahad Khan, Deena Elsori, Meenakshi Verma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 6
CD36 as a double-edged sword in cancer
M. Jiang, Renske Karsenberg, Frans Bianchi, et al.
Immunology Letters (2023) Vol. 265, pp. 7-15
Open Access | Times Cited: 11
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile
Tao Wang, Siqin Wang, Yin‐Xiao Du, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
Hannah Åbacka, Samuele Masoni, Giulio Poli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
Yifan Zhao, Xue Bai, Shujing Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy
Clelia Nisticò, Emanuela Chiarella
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3186-3186
Open Access | Times Cited: 10
Suppression of thrombospondin-1–mediated inflammaging prolongs hematopoietic health span
Pradeep Ramalingam, Michael Gutkin, Michael G. Poulos, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access
Reprogramming of Fatty Acid Metabolism in Acute Leukemia
Judith Sokei, Joice Kanefsky, Stephen M. Sykes
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Closed Access
Dietary Modulation of Fatty Acid Oxidation Imparts Stem Cell Protection in Bone Marrow
Nawaz Ahmed, Sarah Walker, Alessia Roma, et al.
Nutrition and Cancer (2025), pp. 1-7
Closed Access
Discovery and in vitro characterization of a human anti-CD36 scFv
Cecilia Mata-Cruz, Sandra Guerrero-Rodríguez, Keyla Gómez-Castellano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lipid metabolism in cancer: Exploring phospholipids as potential biomarkers
Dominique Delmas, Agnès Mialhe, Alexia K. Cotte, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118095-118095
Closed Access
Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance
Liqun Xia, Zhenwei Zhou, Xianjiong Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115834-115834
Open Access | Times Cited: 9
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1915-1915
Open Access | Times Cited: 2
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Rebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Deciphering the Complexities of Acute Myeloid Leukemia: Emerging Roles of Epithelial to Mesenchymal Transition Transcription Factors (EMT-TFs) in Disease Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
(2024)
Open Access | Times Cited: 1
Metabolic Conditioning Enhances Human bmMSC Therapy of Doxorubicin-Induced Heart Failure
Jacques Virginie, Sabrina Benaouadi, Descamps Jean-Gerard, et al.
Stem Cells (2024) Vol. 42, Iss. 10, pp. 874-888
Closed Access | Times Cited: 1
Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential
Elsa Görsch, Marlon Arnone, Maksim Klimiankou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Epigenenomic and transcriptomic characterization ofNPM1-mutated CN-AML subtypes
Lia N’Guyen, Clara Tellez-Quijorna, Julien Vernerey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinicopathological significance of CD36 expression in oral squamous cell carcinoma
Kotaro Sakurai, Kei Tomihara, Manabu Yamazaki, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top